Loading clinical trials...
Loading clinical trials...
A Better Understanding of the Association Between Problem Gambling and Psychotic Disorders in Young Adults: a New Path Towards Recovery
The aims of this propsective cohort study are to get a better understanding of the association between problem gambling and psychotic disorders among young adults with first-episode psychosis. The main questions to be answered are: 1. What is the incidence of problem gambling in this population? 2. What are the predictors of problem gambling in this population? To do so, putative predictors of problem gambling will be analyzed using Cox regression models: * Sociodemographics (e.g., age, gender identity, ethnicity, level of education, employment); * Psychiatric comorbidities (e.g., substance use disorders, cluster B personality disorders); * Antipsychotic use (first/second-generation, third-generation \[aripiprazole, brexpiprazole, cariprazine\]); * Prior gambling history.
All Cox regression models will be adjusted for site-effect. Further multivariable models will be constructed to examine the association between antipsychotic use (as continuous exposure) and incident PBG using the directed acyclic graphs approach to adjust for confounders.
Age
18 - 35 years
Sex
ALL
Healthy Volunteers
No
Montreal University Hospital Center
Montreal, Quebec, Canada
Quebec Mental Health University Institute
Québec, Quebec, Canada
Start Date
November 1, 2019
Primary Completion Date
May 1, 2023
Completion Date
May 1, 2023
Last Updated
May 28, 2025
520
ACTUAL participants
Antipsychotic use
DRUG
Psychiatric comorbidities
OTHER
Sociodemographics/socioeconomic status
OTHER
Gambling history
OTHER
Clinical variables
OTHER
Lead Sponsor
Laval University
Collaborators
NCT07455929
NCT07460453
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06740383